Citations

Showing 10 of 108119 citations.

Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain
Hooten, W. Michael , Hu, Danqing , Cunningham, Julie M. , Black, John L.

Mayo Clinic

Molecular Pain | May 1, 2019 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/1744806919848929 | PMID 31041874 Get It

The catechol-O-methyltransferase Val158Met polymorphism has been associated with alterations in pain perception, but the influence of the polymorphism on pain perception in patients with chronic pain receiving daily opioid therapy has not been previously reported. The primary aim of this study was to investigate the effects of the catechol-O-methyltransferase Val158Met polymorphism on heat pain perception in a cohort of adults receiving daily opioid therapy for chronic pain. Adults with chronic pain consecutively admitted to an outpatient pain rehabilitation program who met inclusion criteria and were receiving daily opioid therapy were recruited for study participation (N = 142). Individuals were genotyped for catechol-O-methyltransferase Val158Met (rs4680), and the polymorphism was analyzed using an additive and codominant genotype models. The distribution of the Val158Met genotypes was 25% for Val/Val, 41% for Val/Met and 34% for Met/Met (Hardy–Weinberg, P > 0.05). A main effect of genotype was observed for heat pain perception ( P = 0.028). Under the codominant model of allele effects, exploratory post hoc pairwise comparisons adjusted for morphine equivalent dose and pain catastrophizing demonstrated that individuals with the Val/Met genotype were hyperalgesic compared to individuals with the Val/Val ( P = 0.039) and Met/Met ( P = 0.023) genotypes. No significant association was observed between heat pain perception and genotype under the additive model of allele effects. Among patients with chronic pain who were receiving daily opioids, the Val/Met genotype was associated with hyperalgesia using a measure of heat pain perception that has been previously indicative of opioid-induced hyperalgesia in other heterogeneous samples of adults with chronic pain. This study contributes to the emerging understanding of how catechol-O-methyltransferase activity affects pain perception in the context of daily opioid use, and these findings may be useful in the design of future trials aimed at investigating the potential efficacy of ß-2 adrenergic receptor antagonism for opioid-induced hyperalgesia.
Utilization of Overnight Pulse Oximetry in Fibromyalgia Patients
Clark, Stephanie , Salonen, Bradley R. , BS, Neha V Reddy, Mohabbat, Arya B. , Reddy, Neha V , Clark, Stephanie D, Reddy Bs, Neha V

Mayo Clinic

Global Advances in Health and Medicine | May 1, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2164956119847125 | PMID 31069165 Get It

Objective To assess whether the Berlin Sleep Questionnaire and the Snoring, Tired, Observed, Pressure, Body mass, Age, Neck, and Gender questionnaire (STOP-BANG) might be suitable replacements for an overnight sleep pulse oximetry as screening tools for sleep disordered breathing in patients with fibromyalgia. Participants: From June 8, 2018 through July 25, 2018, adult patients with a confirmed diagnosis of fibromyalgia (via the 1990 and/or 2010 American College of Rheumatology Fibromyalgia Classification Criteria) who attended Mayo Clinic’s Fibromyalgia Treatment Program were invited to participate in the study. Methods: The design was a prospective comparative study with a retrospective chart review component. Participants completed 2 validated surveys: the Berlin Sleep Questionnaire and the STOP-BANG. Medical records were reviewed for demographic information and overnight pulse oximetry test results. Results: Results from both questionnaires indicate that there is an association between sleep apnea risk category (defined by questionnaire) and oximetry results. Fisher’s exact test for STOP-BANG and Berlin Sleep Questionnaire are statistically significant ( P < .001), indicating that participants at high risk for sleep apnea (based on the questionnaires) had a greater prevalence of abnormal oximetry results than those at low risk for sleep apnea. Participants who were classified as high risk (85.7%) or intermediate risk (61.5%) on the STOP-BANG questionnaire for sleep apnea had abnormal oximetry results. Participants who scored as high risk (85.7%) for sleep apnea on the Berlin Sleep Questionnaire had abnormal oximetry results. Conclusions: In patients with fibromyalgia, the Berlin Sleep Questionnaire and the STOP-BANG questionnaires could be beneficial in determining the probability of obstructive sleep apnea and the subsequent need for pulse oximetry testing, in higher risk patients.
Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis
Tang, Sharon , Carlos, Camila , Skarlupka, Joseph H. , Gowda, Madhu, Yin, Linda X. , Motz, Kevin , Suen, Garret , Suen, Garret , Motz, Kevin M , Yin, Linda X , Hillel, Alexander T. , Gowda, Madhu, Currie, Cameron R. , Thibeault, Susan L.

Mayo Clinic

mSphere | May 1, 2019 | Volume: 4 | Issue: 3 | Pages: No page available

10.1128/mspheredirect.00211-19 | PMID 31043518 Get It

The laryngotracheal region resides at the intersection between the heavily studied nasal cavity and lungs; however, examination of the microbiome in chronic inflammatory conditions of the subglottis and trachea remains scarce. To date, studies have focused on the microbiota of the vocal folds, or the glottis, for laryngeal carcinoma, as well as healthy larynges, benign vocal fold lesions, and larynges exposed to smoking and refluxate. In this study, we seek to examine the structure and composition of the microbial community in adult laryngotracheal stenosis of various etiologies. Due to the heterogeneity among the underlying pathogenesis mechanisms and clinical outcomes seen in laryngotracheal stenosis disease, we hypothesized that different microbial profiles will be detected among various stenosis etiology types. Understanding differences in the microbiota for subglottic stenosis subtypes may shed light upon etiology-specific biomarker identification and offer novel insights into management approaches for this debilitating disease.
Cardiac prostheses‐related hemolytic anemia
Alkhouli, Mohamad , Farooq, Ali , Balla, Sudarshan , Berzingi, Chalak , Alkhouli, Mohamad , Balla, Sudarshan , Go, Ronald S.

Mayo Clinic

Clinical Cardiology | May 1, 2019 | Volume: 42 | Issue: 7 | Pages: 692-700

10.1002/clc.23191 | PMID 31039274 Get It

AbstractHemolysis is an unintended sequel of temporary or permanent intracardiac devices. However, limited data exist on the characteristics and treatment of hemolysis in patients with cardiac prostheses. This entity, albeit uncommon, often poses significant diagnostic and management challenges to the clinical cardiologist. In this article, we aim to provide a contemporary overview of the incidence, mechanisms, diagnosis, and management of cardiac prosthesis‐related hemolysis.
Qualitative study of implementation of patient self‐reported measures in a consultation‐liaison psychiatry practice
Spaulding, Aaron , Nordan, Lisa, Blanchfield, Lorrie, Asiedu, Gladys B. , Saltivan, Jean, Pecenka, Stacey, Uitti, Ryan J. , Naessens, James M. , Niazi, Shehzad K. , Uitti, Ryan, Naessens, James , Niazi, Shehzad, Spaulding, Aaron

Mayo Clinic

Journal of Evaluation in Clinical Practice | May 1, 2019 | Volume: 25 | Issue: 3 | Pages: 482-490

10.1111/jep.13160 | PMID 31037796 Get It

AbstractRational, aims, and objectivesUnderstanding of barriers and successes associated with the implementation of electronic patient self‐reported measures (ePSRMs) within clinical settings are limited and have not been pursued utilizing implementation science frameworks. This qualitative study is designed to assess staff perceptions of an ePSRM implementation.MethodsThe study took place in an academic hospital's Consultation Liaison Psychiatry practice. Qualitative interviews were conducted with the staff and clinicians from the practice. Participants were directly involved with the implementation and use of the ePSRM system within the Psychiatry practice. Interviews were structured around the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE‐AIM) framework.ResultsParticipants reported increased patient engagement as well as efficiency and time savings. The intervention was perceived to be more challenging for older patients. Facilitators include communicating the ePSRM to patients prior to the care visit, having enough trained staff or super‐users who can assist with technical problems, and having a shorter questionnaire.ConclusionsOverall, assessment of the ePSRM implementation was positive. Staff and clinicians indicated benefits in time, effectiveness, and improvements in patient treatment. Results indicate that defining how the system would fit within the clinical workflow was key, as was a flexible and user‐friendly technology platform. The ePSRM implementation was dependent upon clinical involvement and interest in adoption, while barriers were associated with technical challenges as well as some patient difficulties, such as cognitive impairment. The use of the RE‐AIM framework is valuable as it allows for systematic assessment of the implementation and identifies areas in that implementation has succeeded or is lacking.
Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease
Bhanji, Rahima A. , Montaño‐Loza, Aldo J. , Watt, Kymberly D. , Montano-Loza, Aldo J

Mayo Clinic

Hepatology | May 1, 2019 | Volume: 70 | Issue: 6 | Pages: 2193-2203

10.1002/hep.30686 | PMID 31034656 Get It

Sarcopenia is a common complication of cirrhosis and is defined as a progressive and generalized loss of skeletal muscle mass, strength, and function. Sarcopenia is associated with poor prognosis and increased mortality. How sarcopenia and muscle wasting relate to such poor outcomes requires looking beyond the overt muscle loss and at this entity as a systemic disease that affects muscles of vital organs including cardiac and respiratory muscles. This review explores the pathophysiological pathways and mechanisms that culminate in poor outcomes associated with sarcopenia. This provides a launching pad to identify potential targets for therapeutic intervention and optimization to improve patient outcomes.
Magnetic Resonance Imaging in Primary Sclerosing Cholangitis—Current State and Future Directions
Zenouzi, Roman , Welle, Christopher L. , Venkatesh, Sudhakar K. , Eaton, John E. , Venkatesh, Sudhakar K , Schramm, Christoph

Mayo Clinic

Seminars in Liver Disease | May 1, 2019 | Volume: 39 | Issue: 03 | Pages: 369-380

10.1055/s-0039-1687853 | PMID 31041791 Get It

AbstractPrimary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary inflammation and fibrosis leading to bile duct strictures, cirrhosis, and carries an increased risk of hepatobiliary malignancies. Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice in PSC. As an evolving technology, MRI has other potential applications in the care and study of those patients with PSC. In this review, the authors aim to provide a technical overview on MRI/MRCP and related technologies, summarize its contemporary use in PSC, and discuss its evolving role to predict outcomes and look ahead toward emerging MRI technologies relevant to PSC.
Anecdotes, Decisions, and Physician Assistant Education
Halasy, Michael , Halasy, Michael P

Mayo Clinic

Journal of Physician Assistant Education | May 1, 2019 | Volume: 30 | Issue: 2 | Pages: 77-77

10.1097/jpa.0000000000000249 | PMID 31124815 Get It

Joint Outcomes Following Surgery for Superior Tibiofibular Joint-Associated Peroneal Intraneural Ganglion Cysts
Wilson, Thomas J. , Stone, Jonathan J. , Howe, B. Matthew, Rock, Michael G., Spinner, Robert J.

Mayo Clinic

Neurosurgery | April 30, 2019 | Volume: 86 | Issue: 3 | Pages: 383-390

10.1093/neuros/nyz205 | PMID 31215635 Get It

Abstract BACKGROUND Intraneural ganglion cysts are joint-connected, with the primary pathology residing in the associated joint. For peroneal intraneural ganglion cysts, the surgical strategy can include resection of the synovial surface of the superior tibiofibular joint (STFJ). However, the rate of instability postoperatively is unclear. OBJECTIVE To evaluate the rate of STFJ instability, following surgery for peroneal intraneural ganglion cysts. The second goal of the study was to assess the relationship between volume of resection of the STFJ and risk of extraneural recurrence. METHODS We performed a retrospective analysis of a cohort of patients with peroneal intraneural ganglion cysts. We analyzed clinical factors, including recurrence, and assessed the rate of postoperative STFJ instability. We created 3-dimensional models of the STFJ pre- and postoperatively to compare the volume of resection in recurrent cases and nonrecurrent cases using a case-control design. RESULTS The total cohort consisted of 65 subjects. No patient had evidence of radiological or clinical instability of the STFJ postoperatively. Extraneural radiological recurrence occurred in 6 (9%) patients. No intraneural recurrences were observed. The average volume of resection for patients with recurrence was 1349 mm 3 (SD = 1027 mm 3 ) vs 3018 mm 3 (SD = 1433 mm 3 ) in controls that did not have a recurrence ( P = .018). CONCLUSION This study supports performing an aggressive STFJ resection to minimize the risk of extraneural recurrence. Superior tibiofibular joint resection is not associated with postoperative joint instability. A smaller volume resection is correlated with recurrence risk.
De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel
Sparrow, Miles , Melmed, Gil , Devlin, Shane , Raffals, Laura E. , Loftus, Edward V. , Rubin, David T. , Bressler, Brian , Cheifetz, Adam S. , Jones, Jennifer , Velayos, Fernando, Loftus, Edward V , Melmed, Gil Y , Rubin, David T , Kozuch, Patricia L. , Spiegel, Brennan , Baidoo, Leonard , Irving, Peter Miles , Kaplan, Gilaad G. , Siegel, Corey A

Mayo Clinic

GastroHep | April 30, 2019 | Volume: 1 | Issue: 3 | Pages: 108-117

10.1002/ygh2.337 Get It